COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 296: Articles 2951-2960  | Next

Refining COVID-19 retrospective diagnosis with continuous serological tests: a Bayesian mixture model
Glemain, B., de Lamballerie, X., Zins, M., Severi, G., Touvier, M., Deleuze, J.-F., SAPRIS-SERO study group, , Lapidus, N., Carrat, F.
10.1101/2023.09.15.23295603 — Posted: 2023-09-15
Predictors of COVID-19 Vaccine Acceptability Among Refugees and Other Migrant Populations: A Systematic Scoping Review
Yazdani, Y., Pai, P., Sayfi, S., Mohammadi, A., Perdes, S., Spitzer, D., Fabreau, G., Pottie, K.
10.1101/2023.09.15.23295608 — Posted: 2023-09-15
Clinical Performance of SARS-CoV-2 Rapid Antigen Tests: A Systematic Review and Meta-Analysis
Feng, Q., Germic, N., Hayer, J.
10.1101/2023.09.15.23295560 — Posted: 2023-09-15
MixOmics Integration of Biological Datasets Identifies Highly Correlated Key Variables of COVID-19 severity.
Harriott, N. C., Chimenti, M. S., Ryan, A. L.
10.1101/2023.09.14.557558 — Posted: 2023-09-15
Cooperativity and induced oligomerisation control the interaction of SARS- CoV-2 with its cellular receptor and patient-derived antibodies
Asor, R., Olerinyova, A., Burnap, S. A., Kushwah, M. S., Soltermann, F., Rudden, L. P., Hensen, M., Vasiljevic, S., Brun, J., Hill, M., Chang, L., Dejnirattisai, W., Supasa, P., Mongkolsapaya, J., Zhou, D., Stuart, D. I., Screaton, G., Degiacomi, M., Zitzmann, N., Benesch, J. L., Struwe, W. B., Kukura, P.
10.1101/2023.09.14.557399 — Posted: 2023-09-15
The SARS-CoV-2 nucleoprotein associates with anionic lipid membranes
Dutta, M., Su, Y., Voth, G. A., Stahelin, R. V.
10.1101/2023.09.15.557899 — Posted: 2023-09-15
Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster
Wang, X., Jiang, S., Ma, W., Li, X., Wei, K., Xie, F., Zhao, C., Zhao, X., Li, C., Qiao, R., Cui, Y., Chen, Y., Li, J., Cai, G., Liu, C., Hu, Z., Zhang, W., Li, M., Zhang, Y., Wang, P.
10.1101/2023.09.14.557682 — Posted: 2023-09-15
Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics
Ose, N. J., Campitelli, P. J., Modi, T., Kazan, I. C., Kumar, S., Ozkan, S. B.
10.1101/2023.09.14.557827 — Posted: 2023-09-15
Trajectories and correlates of poor mental health in India over the course of the COVID-19 pandemic: a nation-wide survey
Nichols, E., Petrosyan, S., Khobragade, P., Banerjee, J., Angrisani, M., Dey, S., Bloom, D., Schaner, S., Dey, A., Lee, J.
10.1101/2023.09.13.23295513 — Posted: 2023-09-14
The impact of the COVID-19 pandemic on short-term cancer survival in the United Kingdom: a cohort analysis
Barclay, N. L., Burkard, T., Burn, E., Delmestri, A., Dominguez, A. M., Golozar, A., Guarner-Argente, C., Aviles-Jurado, F.-X., Man, W. Y., Rosello Serrano, A., Weinberger Rosen, A., Tan, E. H., Tietzova, I., OPTIMA Consortium, , PRIETO-ALHAMBRA, D., Newby, D.
10.1101/2023.09.14.23295563 — Posted: 2023-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).